News-Medical.Net on MSN11h
Groundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth Houston
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.
Medical Device Network on MSN12h
C2N Diagnostics lands $10m cash injection from Samsung
C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said ...
Contract Pharma15h
Samsung Invests $10M in CS2 Diagnostics
C2N Diagnostics, LLC, a specialty diagnostics company, has received a $10 million investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment ...